☆ 4.4 Review

The association of fatty liver and risk of hepatocellular carcinoma in HBV or HCV infected individuals: a systematic review and meta-analysis

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Gastroenterology & Hepatology

Increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis with concurrent fatty liver

Mi Na Kim et al.

Summary: This study found that patients with chronic viral hepatitis and concurrent fatty liver have a higher risk of developing hepatocellular carcinoma and mortality, highlighting the importance of managing fatty liver in reducing these risks for patients.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)

Add to Collection

Article Gastroenterology & Hepatology

Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

Sarah Blach et al.

Summary: This study aims to evaluate the burden of hepatitis C virus (HCV) in 2020 and forecast the burden by 2030. Using literature review, Delphi process, and mathematical modelling, it estimated the global prevalence of viraemic HCV infection to be 0.7% in 2020, corresponding to 56.8 million infections. The findings suggest that the current efforts are not on track to achieve the global elimination targets by 2030.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2022)

Add to Collection

Article Oncology

Impact of PNPLA3 p.I148M and Hepatic Steatosis on Long-Term Outcomes for Hepatocellular Carcinoma and HBsAg Seroclearance in Chronic Hepatitis B

Rei-Chi Hsueh et al.

Summary: This study found that hepatic steatosis and the PNPLA3-148M variant have distinct impacts on the development of HBV-related liver disease and hepatocellular carcinoma (HCC). The PNPLA3-148M variant can help identify HBV carriers with a high risk of fatty liver disease progressing to HCC.

JOURNAL OF HEPATOCELLULAR CARCINOMA (2022)

Add to Collection

Review Gastroenterology & Hepatology

Epidemiology of Hepatocellular Carcinoma

Katherine A. McGlynn et al.

Summary: Liver cancer, particularly hepatocellular carcinoma (HCC), is a major global health concern. While HBV and HCV remain important risk factors for HCC, efforts in vaccination and treatment are showing promise. However, the increasing prevalence of metabolic risk factors like obesity and diabetes, as well as other factors like excessive alcohol consumption, present ongoing challenges in the prevention of liver cancer.

HEPATOLOGY (2021)

Add to Collection

Article Immunology

Association Between Fatty Liver and Cirrhosis, Hepatocellular Carcinoma, and Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B

Jie Li et al.

Summary: This study found that concurrent FL in patients with CHB significantly reduces the risk of cirrhosis and HCC, as well as increases the rate of HBsAg seroclearance. Further research is needed to confirm these findings and investigate the underlying mechanisms of FL on CHB.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Review Gastroenterology & Hepatology

Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta-analysis

Cori Campbell et al.

Summary: Hepatocellular carcinoma (HCC) is a major cause of cancer mortality globally, particularly in individuals with chronic hepatitis B virus (HBV) infection. Research shows that diabetes mellitus (DM) is significantly associated with an increased risk of HCC, emphasizing the need for enhanced screening of HBV and diabetic patients.

JOURNAL OF VIRAL HEPATITIS (2021)

Add to Collection

Article Oncology

ALT Flare Predicts Hepatocellular Carcinoma Among Antiviral Treated Patients With Chronic Hepatitis B: A Cross-Country Cohort Study

Yanan Du et al.

Summary: This study investigated the association between ALT level and HCC occurrence in NA-treated CHB patients. The results showed a positive correlation between ALT level and HCC, with higher risks observed in patients with ALT flare. Elevation of ALT, especially ALT flare, is a strong predictor for HCC occurrence and requires close monitoring for early detection.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Article Gastroenterology & Hepatology

Reduced hepatic steatosis is associated with higher risk of hepatocellular carcinoma in chronic hepatitis B infection

Lung-Yi Mak et al.

Summary: The study revealed an association between hepatic steatosis and the development of HCC in CHB patients, demonstrating that reduced hepatic steatosis is significantly associated with a higher risk of incident HCC. Routine measurements of CAP and LS are important for risk stratification.

HEPATOLOGY INTERNATIONAL (2021)

Add to Collection

Article Gastroenterology & Hepatology

Earlier Alanine Aminotransferase Normalization During Antiviral Treatment Is Independently Associated With Lower Risk of Hepatocellular Carcinoma in Chronic Hepatitis B

Jonggi Choi et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Exercise retards hepatocarcinogenesis in obese mice independently of weight control

Arfianti Arfianti et al.

JOURNAL OF HEPATOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B

Teng-Yu Lee et al.

JAMA INTERNAL MEDICINE (2019)

Add to Collection

Article Gastroenterology & Hepatology

Suboptimal SVR rates in African patients with atypical genotype 1 subtypes: Implications for global elimination of hepatitis C

Kate Childs et al.

JOURNAL OF HEPATOLOGY (2019)

Add to Collection

Article Gastroenterology & Hepatology

Metformin modulates innate immune-mediated inflammation and early progression of NAFLD-associated hepatocellular carcinoma in zebrafish

Sofia de Oliveira et al.

JOURNAL OF HEPATOLOGY (2019)

Add to Collection

Article Gastroenterology & Hepatology

Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B

Yun Bin Lee et al.

CLINICAL AND MOLECULAR HEPATOLOGY (2019)

Add to Collection

Article Gastroenterology & Hepatology

The association between steatosis and diabetes with hepatocellular carcinoma in non-genotype 3 chronic hepatitis C patients

Yi-Hao Yen et al.

LIVER INTERNATIONAL (2018)

Add to Collection

Article Health Care Sciences & Services

Empirical Comparison of Publication Bias Tests in Meta-Analysis

Lifeng Lin et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2018)

Add to Collection

Article Gastroenterology & Hepatology

Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030

Chris Estes et al.

JOURNAL OF HEPATOLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B

Anthony W. H. Chan et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2017)

Add to Collection

Article Medicine, Research & Experimental

Association Between Hepatocellular Carcinoma and Type 2 Diabetes Mellitus in Chinese Hepatitis B Virus Cirrhosis Patients: A Case-Control Study

Huixian Han et al.

MEDICAL SCIENCE MONITOR (2017)

Add to Collection

Article Gastroenterology & Hepatology

Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes

Zobair M. Younossi et al.

HEPATOLOGY (2016)

Add to Collection

Article Gastroenterology & Hepatology

Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B

Jaemin Lee et al.

CLINICAL AND MOLECULAR HEPATOLOGY (2016)

Add to Collection

Review Medicine, General & Internal

Nonalcoholic Fatty Liver Disease A Systematic Review

Mary E. Rinella

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)

Add to Collection

Review Immunology

Antiviral therapy for chronic hepatitis B in China

Xin Zheng et al.

MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2015)

Add to Collection

Article Gastroenterology & Hepatology

α-Fetoprotein Levels After Interferon Therapy and Risk of Hepatocarcinogenesis in Chronic Hepatitis C

Yasuhiro Asahina et al.

HEPATOLOGY (2013)

Add to Collection

Article Gastroenterology & Hepatology

Hepatitis B virus infection and fatty liver in the general population

Vincent Wai-Sun Wong et al.

JOURNAL OF HEPATOLOGY (2012)

Add to Collection

Article Gastroenterology & Hepatology

Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis C

Hirokazu Takahashi et al.

JOURNAL OF GASTROENTEROLOGY (2011)

Add to Collection

Article Gastroenterology & Hepatology

HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis

G. Nkontchou et al.

JOURNAL OF VIRAL HEPATITIS (2011)

Add to Collection

Editorial Material Public, Environmental & Occupational Health

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

Andreas Stang

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)

Add to Collection

Review Gastroenterology & Hepatology

Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection

Brad Q. Starley et al.

HEPATOLOGY (2010)

Add to Collection

Review Medicine, General & Internal

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

David Moher et al.

PLOS MEDICINE (2009)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Imaging features of perivascular fatty infiltration of the liver: Initial observations

OW Hamer et al.

RADIOLOGY (2005)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Macrovesicular hepatic steatosis in living related liver donors: Correlation between CT and histologic findings

P Limanond et al.

RADIOLOGY (2004)

Add to Collection

Article Gastroenterology & Hepatology

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

LE Adinolfi et al.

HEPATOLOGY (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.